Same Indication

Lisinopril vs Pembrolizumab

Lisinopril vs Pembrolizumab: Overview

This comparison examines the pharmacological differences between Lisinopril and Pembrolizumab.

Mechanism of Action

Lisinopril: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Pharmacokinetics

Half-life: Lisinopril β€” 12 hours; Pembrolizumab β€” 26 days.

Chemical Properties

Molecular Formula: Lisinopril β€” C21H31N3O5.

Molecular Weight: Lisinopril β€” 405.4900 g/mol.

Type: Lisinopril β€” Small molecule; Pembrolizumab β€” Antibody.